← 產業報告目錄

In Vitro Diagnostics (IVD) Quality Control Market by Product & Service (QC (Plasma, Serum, Blood), Solutions), Technology (Immunoassay, MDx, Microbiology, Hematology), Manufacturer (Third-party, OEM), End User (Hospitals, Labs) - Global Forecast to 2030

出版商 MarketsandMarkets產業別 Medical Devices出版日期 2025-09-19頁數 379報告編號 MD4180

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The IVD quality controls market is valued at an estimated USD 1.65 billion in 2025 and is projected to reach USD 2.15 billion by 2030, at a CAGR of 5.5% during the forecast period. IVD quality controls play a critical role in ensuring the accuracy, reliability, and consistency of diagnostic test results across clinical laboratories and healthcare facilities. The growing adoption of third-party quality controls is one of the major drivers of the IVD quality controls market. Unlike instrument-specific controls, third-party solutions offer greater flexibility, compatibility across multiple platforms, and longer shelf life. They provide unbiased performance assessment and consistent analyte stability, helping laboratories maintain reproducible and reliable results. With increasing regulatory and accreditation requirements, laboratories are favoring third-party controls to ensure compliance while optimizing workflow efficiency. The rising use of multianalyte controls further enhances demand, allowing simultaneous monitoring of multiple assays and reducing operational costs. Hospitals and clinical laboratories, in particular, are adopting these solutions to support high-volume testing and diverse diagnostic applications. This shift toward third-party quality controls continues to drive innovation, adoption, and sustained growth in the global IVD quality controls market. “By product & service, the quality control products segment dominated the IVD quality controls market in 2024.” By product & service, the IVD quality controls market is segmented into quality control products, data management solutions, and quality assurance services. In 2024, quality control products held the largest share, driven by the increasing number of diagnostic tests and the need for accurate, reliable, and reproducible results. Regulatory and accreditation requirements further support their adoption, as laboratories aim to maintain compliance and ensure patient safety. Quality control products enable consistent performance monitoring across multiple assays and platforms, helping reduce errors and improve workflow efficiency. The rising use of third-party and multianalyte controls has further strengthened this segment, allowing simultaneous testing of multiple analytes while optimizing operational costs. Overall, QC products remain the backbone of laboratory quality management, making them the dominant segment within the IVD quality controls market. “By manufacturer type, the third-party controls segment is projected to achieve the highest growth during the forecast period.” By manufacturer type, the IVD quality controls market is segmented into third-party controls and original equipment manufacturer (OEM) controls. Third-party controls are projected to be the fastest-growing segment during the forecast period. Their compatibility across multiple platforms, longer shelf life, and unbiased performance assessment make them increasingly preferred by laboratories. Third-party controls also support multianalyte testing and standardized QC procedures, helping laboratories improve workflow efficiency and ensure reproducible results. While OEM controls remain important for instrument-specific applications, the growing demand for versatile, cost-effective, and reliable solutions continues to drive the rapid adoption of third-party controls globally. “The Asia Pacific is projected to be the fastest-growing regional market during the forecast period.” The market for IVD quality controls is categorized into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific is anticipated to be the fastest-growing region in the IVD quality controls market during the forecast period, driven by the rapid development of healthcare infrastructure and increasing investment in advanced diagnostic technologies. The region is witnessing a growing number of clinical laboratories, hospitals, and diagnostic centers, which is boosting the demand for reliable and accurate quality control products. Rising awareness about the importance of early disease detection, coupled with regulatory initiatives to improve laboratory standards, is further supporting market growth. Additionally, the expanding patient population and the rising prevalence of chronic and infectious diseases are creating strong demand for quality control solutions to ensure accuracy and reproducibility. Breakdown of the profiles of primary participants in the IVD quality controls market: • By Company Type: Tier 1 (40%), Tier 2 (30%), and Tier 3 (30%) • By Designation: C-level Executives (27%), Director-level Executives (18%), and Others (55%) • By Region: North America (51%), Europe (21%), Asia Pacific (18%), Latin America (6%), and the Middle East & Africa (4%) The key players in the IVD quality controls market are Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific Inc. (US), Abbott (US), LGC Limited (UK), F. Hoffmann-La Roche Ltd. (Switzerland), Randox Laboratories Ltd. (UK), Siemens Healthineers AG (Germany), QuidelOrtho Corporation (US), Danaher Corporation (US), Sysmex Corporation (Japan), Bio-Techne Corporation (US), Microbix Biosystems Inc. (Canada), Microbiologics, Inc. (US), ZeptoMetrix (US), Fortress Diagnostics (UK), Helena Laboratories Corporation (US), Streck, Inc. (US), SERO AS (Norway), Maine Molecular Quality Controls, Inc. (US), Sun Diagnostics, LLC (US), Alpha-Tec (US), Grifols, S.A. (Spain), ConeBioproducts (US), Eurotrol B.V. (Netherlands), and Biorex Diagnostics (UK). Research Coverage: This research report categorizes the IVD quality controls market by product & service (quality control products, data management solutions, and quality assurance services), technology (immunoassays, clinical chemistry, molecular diagnostics, microbiology, hematology, coagulation & hemostasis, and other technologies), manufacturer type [third-party controls ([independent controls, instrument-specific controls), original equipment manufacturer controls], end user (hospitals, clinical laboratories, academic & research institutes, and other end users), and region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges influencing the growth of the IVD quality controls market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, key strategies, acquisitions, and agreements. A competitive analysis of upcoming startups in the IVD quality controls market ecosystem is covered in this report. Reasons to Buy this Report: The report will help market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall IVD quality controls market and the subsegments. It will also help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, opportunities, and challenges. The report provides insights into the following pointers: • Analysis of key drivers (increasing number of accredited clinical laboratories, growing adoption of third-party quality controls, rising demand for external quality assessment support, rising geriatric population and subsequent growth in prevalence of chronic and infectious diseases, and increasing adoption of PoC instruments in developed regions), opportunities (rising demand for multianalyte controls and increasing growth opportunities in emerging economies), restraints (additional costs and budget constraints in hospitals and laboratories and unfavorable reimbursement scenario for IVD tests), and challenges (stringent product approval process and lack of regulations for clinical laboratory accreditation in several emerging countries) influencing the growth of the IVD quality controls market. • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the IVD quality controls market • Market Development: Comprehensive information about lucrative markets across varied regions • Market Diversification: Exhaustive information about products, untapped geographies, recent developments, and investments in the IVD quality controls market • Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players like Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific Inc. (US), Abbott (US), LGC Limited (UK), and F. Hoffmann-La Roche Ltd. (Switzerland)
目錄 Table of Contents
1 INTRODUCTION 34 1.1 STUDY OBJECTIVES 34 1.2 MARKET DEFINITION 34 1.3 STUDY SCOPE 35 1.3.1 MARKETS COVERED & REGIONAL SCOPE 35 1.4 INCLUSIONS & EXCLUSIONS 36 1.4.1 YEARS CONSIDERED 37 1.5 CURRENCY CONSIDERED 37 1.6 KEY STAKEHOLDERS 37 1.7 SUMMARY OF CHANGES 38 2 RESEARCH METHODOLOGY 39 2.1 RESEARCH DATA 39 2.2 RESEARCH APPROACH 39 2.2.1 SECONDARY DATA 40 2.2.1.1 Key secondary sources 40 2.2.1.2 Key data from secondary sources 41 2.2.2 PRIMARY DATA 42 2.2.2.1 Primary sources 42 2.2.2.2 Key data from primary sources 43 2.2.2.3 Key industry insights 44 2.2.2.4 Breakdown of primary interviews 44 2.3 MARKET SIZE ESTIMATION 45 2.3.1 BOTTOM-UP APPROACH 45 2.3.1.1 Approach 1: Company revenue estimation approach 46 2.3.1.2 Approach 2: Presentations of companies and primary interviews 46 2.3.1.3 Growth forecast 46 2.3.1.4 CAGR projections 47 2.3.2 TOP-DOWN APPROACH 47 2.4 MARKET BREAKDOWN & DATA TRIANGULATION 49 2.5 MARKET SHARE ASSESSMENT 49 2.6 RESEARCH ASSUMPTIONS 50 2.6.1 PARAMETRIC ASSUMPTIONS 50 2.7 RESEARCH LIMITATIONS 50 2.8 RISK ASSESSMENT 51 3 EXECUTIVE SUMMARY 52   4 PREMIUM INSIGHTS 56 4.1 IVD QUALITY CONTROLS MARKET OVERVIEW 56 4.2 IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2025 VS. 2030 57 4.3 IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2025 VS. 2030 57 4.4 IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2025 VS. 2030 58 4.5 IVD QUALITY CONTROLS MARKET, BY END USER, 2025 VS. 2030 58 4.6 IVD QUALITY CONTROLS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 59 5 MARKET OVERVIEW 60 5.1 INTRODUCTION 60 5.2 MARKET DYNAMICS 60 5.2.1 DRIVERS 61 5.2.1.1 Increasing number of accredited clinical laboratories 61 5.2.1.2 Growing adoption of third-party quality controls 62 5.2.1.3 Rising demand for external quality assessment support 62 5.2.1.4 Rising geriatric population and subsequent growth in prevalence of chronic and infectious diseases 63 5.2.1.5 Increasing adoption of POC instruments in developed regions 64 5.2.2 RESTRAINTS 65 5.2.2.1 Additional costs and budget constraints in hospitals and laboratories 65 5.2.2.2 Unfavorable reimbursement scenario for IVD tests 65 5.2.3 OPPORTUNITIES 66 5.2.3.1 Rising demand for multianalyte controls 66 5.2.3.2 Increasing growth opportunities in emerging economies 66 5.2.4 CHALLENGES 67 5.2.4.1 Stringent product approval process 67 5.2.4.2 Lack of regulations for clinical laboratory accreditation in several emerging countries 67 5.3 PRICING ANALYSIS 68 5.3.1 AVERAGE SELLING PRICE TREND OF IVD QUALITY CONTROL PRODUCTS, 2023–2025 68 5.3.2 AVERAGE SELLING PRICE TREND OF IVD QUALITY CONTROLS, BY KEY PLAYER, 2023–2025 68 5.3.3 AVERAGE SELLING PRICE TREND OF IVD QUALITY CONTROL PRODUCTS, BY REGION, 2023–2025 70 5.4 PATENT ANALYSIS 71 5.4.1 LIST OF MAJOR PATENTS 72 5.5 VALUE CHAIN ANALYSIS 73 5.6 SUPPLY CHAIN ANALYSIS 74 5.7 TRADE ANALYSIS 75 5.7.1 IMPORT DATA (HS CODE 3822) 76 5.7.2 EXPORT DATA (HS CODE 3822) 76   5.8 ECOSYSTEM ANALYSIS 77 5.8.1 IVD QUALITY CONTROLS MARKET: ROLE OF COMPANIES IN ECOSYSTEM 78 5.9 PORTER’S FIVE FORCES ANALYSIS 79 5.9.1 THREAT OF NEW ENTRANTS 80 5.9.2 THREAT OF SUBSTITUTES 80 5.9.3 BARGAINING POWER OF BUYERS 80 5.9.4 BARGAINING POWER OF SUPPLIERS 80 5.9.5 INTENSITY OF COMPETITIVE RIVALRY 80 5.10 REGULATORY ANALYSIS 81 5.10.1 REGULATORY FRAMEWORK 81 5.10.1.1 North America 81 5.10.1.1.1 US 81 5.10.1.1.2 Canada 82 5.10.1.2 Europe 83 5.10.1.2.1 Germany 84 5.10.1.2.2 UK 84 5.10.1.2.3 France 85 5.10.1.2.4 Italy 85 5.10.1.3 Asia Pacific 85 5.10.1.3.1 China 85 5.10.1.3.2 Japan 85 5.10.1.3.3 India 86 5.10.1.4 Latin America 87 5.10.1.4.1 Brazil 87 5.10.1.4.2 Mexico 87 5.10.1.5 Middle East 88 5.10.1.6 Africa 88 5.10.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 88 5.11 TECHNOLOGY ANALYSIS 90 5.11.1 KEY TECHNOLOGIES 91 5.11.1.1 Immunoassays 91 5.11.2 COMPLEMENTARY TECHNOLOGIES 91 5.11.2.1 Molecular diagnostics 91 5.11.3 ADJACENT TECHNOLOGIES 92 5.11.3.1 Clinical chemistry 92 5.12 KEY CONFERENCES & EVENTS, 2025–2026 92 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 93 5.14 KEY STAKEHOLDERS & BUYING CRITERIA 94 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 94 5.14.2 BUYING CRITERIA 94   5.15 INVESTMENT & FUNDING SCENARIO 95 5.16 CASE STUDY ANALYSIS 96 5.16.1 CASE STUDY 1: QUALITY CONTROL DATA MANAGEMENT WITH UNITY REAL-TIME IN MOLECULAR VIROLOGY 96 5.16.2 CASE STUDY 2: ENHANCING RELIABILITY OF INFLUENZA DIAGNOSTICS WITH EXTERNAL QUALITY CONTROLS 96 5.17 IMPACT OF AI/GENERATIVE AI ON IVD QUALITY CONTROLS MARKET 97 5.17.1 INTRODUCTION 97 5.17.2 MARKET POTENTIAL OF AI 97 5.17.3 AI USE CASES 98 5.17.4 IMPLEMENTATION OF AI, BY KEY COMPANY AND USE CASE 99 5.17.5 FUTURE OF AI IN IVD QUALITY CONTROLS MARKET 99 5.18 IMPACT OF 2025 US TARIFFS ON IVD QUALITY CONTROLS MARKET 99 5.18.1 INTRODUCTION 99 5.18.2 KEY TARIFF RATES 100 5.18.3 PRICE IMPACT ANALYSIS 100 5.18.4 IMPACT ON COUNTRY/REGION 101 5.18.4.1 North America 101 5.18.4.2 Europe 101 5.18.4.3 Asia Pacific 101 5.18.5 IMPACT ON END-USE INDUSTRIES 101 5.18.5.1 Hospitals 101 5.18.5.2 Clinical laboratories 102 5.18.5.3 Academic & research institutes 102 6 IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE 103 6.1 INTRODUCTION 104 6.2 QUALITY CONTROL PRODUCTS 104 6.2.1 SERUM/PLASMA-BASED CONTROLS 108 6.2.1.1 Greater stability and accuracy of diagnostic test results to increase demand for serum/plasma-based controls 108 6.2.2 WHOLE BLOOD-BASED CONTROLS 112 6.2.2.1 Rising need to ensure high-quality clinical test results to drive market 112 6.2.3 URINE-BASED CONTROLS 115 6.2.3.1 Growing incidence of kidney diseases to drive demand for urine-based controls 115 6.2.4 OTHER CONTROLS 119 6.3 DATA MANAGEMENT SOLUTIONS 123 6.3.1 RISING FOCUS ON IMPROVING ANALYTICAL PERFORMANCE OF CLINICAL LABORATORIES TO SUPPORT MARKET GROWTH 123 6.4 QUALITY ASSURANCE SERVICES 126 6.4.1 GROWING NEED FOR PERFORMANCE ASSESSMENT OF CLINICAL LABORATORIES TO INCREASE DEMAND FOR QUALITY ASSURANCE SERVICES 126 7 IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY 129 7.1 INTRODUCTION 130 7.2 IMMUNOASSAYS 130 7.2.1 FOCUS ON MONITORING PRECISION OF IMMUNOASSAY TESTS TO DRIVE ADOPTION OF IMMUNOASSAY CONTROLS 130 7.3 CLINICAL CHEMISTRY 134 7.3.1 RISING INCIDENCE OF LIFESTYLE DISEASES TO PROVIDE OPPORTUNITIES FOR MARKET GROWTH 134 7.4 MOLECULAR DIAGNOSTICS 138 7.4.1 GROWING INCIDENCE OF INFECTIOUS DISEASES TO DRIVE DEMAND FOR MOLECULAR DIAGNOSTIC CONTROLS 138 7.5 MICROBIOLOGY 142 7.5.1 INCREASING ADOPTION OF AUTOMATED CLINICAL MICROBIOLOGY TESTING INSTRUMENTS TO SUPPORT MARKET GROWTH 142 7.6 HEMATOLOGY 146 7.6.1 NEED FOR ACCURACY IN HEMATOLOGICAL TEST RESULTS TO DRIVE RELIANCE ON HEMATOLOGY QUALITY CONTROLS 146 7.7 COAGULATION & HEMOSTASIS 150 7.7.1 GROWING NUMBER OF CARDIOVASCULAR SURGERIES TO DRIVE DEMAND FOR COAGULATION & HEMOSTASIS TESTING 150 7.8 OTHER TECHNOLOGIES 153 8 IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE 157 8.1 INTRODUCTION 158 8.2 THIRD-PARTY CONTROLS 158 8.2.1 INDEPENDENT CONTROLS 162 8.2.1.1 Unbiased and independent performance assessment for analytical processes to drive adoption 162 8.2.2 INSTRUMENT-SPECIFIC CONTROLS 165 8.2.2.1 Dependence on instrument-specific compatibility to restrict demand 165 8.3 ORIGINAL EQUIPMENT MANUFACTURER CONTROLS 168 8.3.1 OEM CONTROLS TO WITNESS LOWER ADOPTION AS THEY ARE LESS SENSITIVE TO QC-RELATED ISSUES 168 9 IVD QUALITY CONTROLS MARKET, BY END USER 172 9.1 INTRODUCTION 173 9.2 HOSPITALS 173 9.2.1 LARGE VOLUME OF IVD PROCEDURES PERFORMED TO DRIVE MARKET 173 9.3 CLINICAL LABORATORIES 176 9.3.1 GROWING NUMBER OF ACCREDITED LABORATORIES TO DRIVE MARKET 176 9.4 ACADEMIC & RESEARCH INSTITUTES 179 9.4.1 RISING FOCUS ON ACCURATE RESEARCH RESULTS TO SUPPORT MARKET GROWTH 179 9.5 OTHER END USERS 182 10 IVD QUALITY CONTROLS MARKET, BY REGION 186 10.1 INTRODUCTION 187 10.2 NORTH AMERICA 187 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 192 10.2.2 US 192 10.2.2.1 High healthcare expenditure to propel market growth 192 10.2.3 CANADA 195 10.2.3.1 Government initiatives and research funding to support market growth 195 10.3 EUROPE 198 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 202 10.3.2 GERMANY 202 10.3.2.1 Rising volume of high-quality tests performed to support market growth 202 10.3.3 UK 205 10.3.3.1 Growing number of diagnostic centers to drive market 205 10.3.4 FRANCE 208 10.3.4.1 Increasing prevalence of infectious diseases and growing demand for early diagnosis to drive market 208 10.3.5 ITALY 211 10.3.5.1 Growing disease prevalence to drive demand for better and more accurate disease diagnosis 211 10.3.6 SPAIN 213 10.3.6.1 Rising incidence of chronic diseases to support market growth 213 10.3.7 RUSSIA 216 10.3.7.1 Increasing access to quality healthcare and growing incidence of lifestyle and infectious diseases to drive market 216 10.3.8 REST OF EUROPE 219 10.4 ASIA PACIFIC 222 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 227 10.4.2 CHINA 227 10.4.2.1 Growing access to modern healthcare and government support to boost market growth 227 10.4.3 JAPAN 230 10.4.3.1 Well-developed healthcare system and demand for improvements in quality of IVD test results to drive market 230 10.4.4 INDIA 233 10.4.4.1 Rising need to secure NABL accreditations to drive demand for quality controls 233 10.4.5 AUSTRALIA 236 10.4.5.1 Initiatives to enhance access to healthcare and improve infrastructure to propel market growth 236 10.4.6 SOUTH KOREA 239 10.4.6.1 Rising healthcare expenditure and growing number of hospitals to drive market 239 10.4.7 REST OF ASIA PACIFIC 242 10.5 LATIN AMERICA 245 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 249 10.5.2 BRAZIL 249 10.5.2.1 Brazil to dominate Latin American IVD quality controls market 249 10.5.3 MEXICO 252 10.5.3.1 Increasing number of accredited clinical laboratories to support market growth 252 10.5.4 REST OF LATIN AMERICA 255 10.6 MIDDLE EAST & AFRICA 258 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 262 10.6.2 SAUDI ARABIA 262 10.6.2.1 Rising government healthcare expenditure to boost market 262 10.6.3 UAE 265 10.6.3.1 Improvements in healthcare infrastructure to support growth 265 10.6.4 REST OF MIDDLE EAST & AFRICA 268 11 COMPETITIVE LANDSCAPE 272 11.1 INTRODUCTION 272 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 272 11.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN IVD QUALITY CONTROLS MARKET 273 11.3 REVENUE ANALYSIS, 2022–2024 275 11.4 MARKET SHARE ANALYSIS, 2024 276 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 278 11.5.1 STARS 278 11.5.2 EMERGING LEADERS 278 11.5.3 PERVASIVE PLAYERS 278 11.5.4 PARTICIPANTS 278 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 280 11.5.5.1 Company footprint 280 11.5.5.2 Region footprint 281 11.5.5.3 Product & service footprint 282 11.5.5.4 Technology footprint 283 11.5.5.5 Manufacturer type footprint 284 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 285 11.6.1 PROGRESSIVE COMPANIES 285 11.6.2 RESPONSIVE COMPANIES 285 11.6.3 DYNAMIC COMPANIES 285 11.6.4 STARTING BLOCKS 285 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 287 11.6.5.1 Detailed list of key startups/SMEs 287 11.6.5.2 Competitive benchmarking of key emerging players/startups, by product & service and manufacturer type 287 11.6.5.3 Competitive benchmarking of key startups/SMEs, by region 288 11.7 COMPANY VALUATION & FINANCIAL METRICS 288 11.7.1 FINANCIAL METRICS 288 11.7.2 COMPANY VALUATION 289 11.8 BRAND/PRODUCT COMPARISON 289 11.8.1 BRAND/PRODUCT COMPARATIVE ANALYSIS 289 11.9 COMPETITIVE SCENARIO 290 11.9.1 PRODUCT & SERVICE LAUNCHES AND APPROVALS 290 11.9.2 DEALS 291 11.9.3 EXPANSIONS 292 12 COMPANY PROFILES 293 12.1 KEY PLAYERS 293 12.1.1 BIO-RAD LABORATORIES, INC. 293 12.1.1.1 Business overview 293 12.1.1.2 Products & services offered 294 12.1.1.3 Recent developments 299 12.1.1.3.1 Product & service launches 299 12.1.1.3.2 Deals 299 12.1.1.4 MnM view 299 12.1.1.4.1 Key strengths 299 12.1.1.4.2 Strategic choices 300 12.1.1.4.3 Weaknesses & competitive threats 300 12.1.2 THERMO FISHER SCIENTIFIC, INC. 301 12.1.2.1 Business overview 301 12.1.2.2 Products & services offered 302 12.1.2.3 Recent developments 304 12.1.2.3.1 Deals 304 12.1.2.4 MnM view 305 12.1.2.4.1 Key strengths 305 12.1.2.4.2 Strategic choices 305 12.1.2.4.3 Weaknesses & competitive threats 305 12.1.3 ABBOTT 306 12.1.3.1 Business overview 306 12.1.3.2 Products & services offered 307 12.1.3.3 MnM view 309 12.1.3.3.1 Key strengths 309 12.1.3.3.2 Strategic choices 309 12.1.3.3.3 Weaknesses & competitive threats 309   12.1.4 LGC LIMITED 310 12.1.4.1 Business overview 310 12.1.4.2 Products & services offered 311 12.1.4.3 Recent developments 314 12.1.4.3.1 Deals 314 12.1.4.4 MnM view 315 12.1.4.4.1 Key strengths 315 12.1.4.4.2 Strategic choices 315 12.1.4.4.3 Weaknesses & competitive threats 315 12.1.5 F. HOFFMANN-LA ROCHE LTD. 316 12.1.5.1 Business overview 316 12.1.5.2 Products & services offered 317 12.1.5.3 Recent developments 318 12.1.5.3.1 Deals 318 12.1.5.4 MnM view 319 12.1.5.4.1 Key strengths 319 12.1.5.4.2 Strategic choices 319 12.1.5.4.3 Weaknesses & competitive threats 319 12.1.6 RANDOX LABORATORIES LTD. 320 12.1.6.1 Business overview 320 12.1.6.2 Products & services offered 320 12.1.6.3 Recent developments 324 12.1.6.3.1 Product & service launches 324 12.1.6.3.2 Deals 324 12.1.7 SIEMENS HEALTHINEERS AG 325 12.1.7.1 Business overview 325 12.1.7.2 Products & services offered 326 12.1.8 QUIDELORTHO CORPORATION 327 12.1.8.1 Business overview 327 12.1.8.2 Products & services offered 328 12.1.8.3 Recent developments 330 12.1.8.3.1 Deals 330 12.1.8.3.2 Expansions 330 12.1.9 DANAHER CORPORATION 331 12.1.9.1 Business overview 331 12.1.9.2 Products & services offered 332 12.1.10 SYSMEX CORPORATION 334 12.1.10.1 Business overview 334 12.1.10.2 Products & services offered 335 12.1.10.3 Recent developments 336 12.1.10.3.1 Product & service launches 336 12.1.10.3.2 Deals 336 12.1.10.3.3 Expansions 337 12.1.11 BIO-TECHNE CORPORATION 339 12.1.11.1 Business overview 339 12.1.11.2 Products & services offered 340 12.1.11.3 Recent developments 344 12.1.11.3.1 Product & service launches 344 12.1.11.3.2 Deals 344 12.1.11.3.3 Expansions 345 12.1.12 MICROBIX BIOSYSTEMS INC. 346 12.1.12.1 Business overview 346 12.1.12.2 Products & services offered 347 12.1.12.3 Recent developments 348 12.1.12.3.1 Product & service launches 348 12.1.12.3.2 Deals 349 12.1.13 GRIFOLS, S.A. 351 12.1.13.1 Business overview 351 12.1.13.2 Products & services offered 352 12.1.14 MICROBIOLOGICS, INC. 353 12.1.14.1 Business overview 353 12.1.14.2 Products & services offered 353 12.1.14.3 Recent developments 355 12.1.14.3.1 Deals 355 12.1.15 ZEPTOMETRIX 356 12.1.15.1 Business overview 356 12.1.15.2 Products & services offered 356 12.1.15.3 Recent developments 357 12.1.15.3.1 Product & service launches & approvals 357 12.1.16 FORTRESS DIAGNOSTICS 359 12.1.16.1 Business overview 359 12.1.16.2 Products & services offered 359 12.2 OTHER PLAYERS 362 12.2.1 HELENA LABORATORIES CORPORATION 362 12.2.2 STRECK, INC. 363 12.2.3 MAINE MOLECULAR QUALITY CONTROLS, INC. 364 12.2.4 SUN DIAGNOSTICS, LLC 366 12.2.5 SERO AS 366 12.2.6 CONEBIOPRODUCTS 367 12.2.7 ALPHA-TEC 368 12.2.8 EUROTROL B.V. 369 12.2.9 BIOREX DIAGNOSTICS 370   13 APPENDIX 371 13.1 DISCUSSION GUIDE 371 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 375 13.3 CUSTOMIZATION OPTIONS 377 13.4 RELATED REPORTS 377 13.5 AUTHOR DETAILS 378
圖表清單 List of Tables & Figures
TABLE 1 IVD QUALITY CONTROLS MARKET: KEY DATA FROM PRIMARY SOURCES 43 TABLE 2 IVD QUALITY CONTROLS MARKET: RISK ASSESSMENT ANALYSIS 51 TABLE 3 NUMBER OF CANCER PATIENTS WORLDWIDE, BY REGION, 2022 VS. 2035 VS. 2045 64 TABLE 4 AVERAGE SELLING PRICING TREND OF IVD QUALITY CONTROL PRODUCTS, 2023–2025 (USD) 68 TABLE 5 AVERAGE SELLING PRICE TREND OF IVD QUALITY CONTROLS, BY KEY PLAYER, 2023–2025 (USD) 69 TABLE 6 AVERAGE SELLING PRICE TREND OF IVD QUALITY CONTROL PRODUCTS, BY REGION, 2023–2025 (USD) 70 TABLE 7 LIST OF MAJOR PATENTS, 2023–2025 72 TABLE 8 IMPORT DATA FOR HS CODE 3822-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD MILLION) 76 TABLE 9 EXPORT DATA FOR HS CODE 3822-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD MILLION) 77 TABLE 10 IMPACT OF PORTER’S FORCES ON IVD QUALITY CONTROLS MARKET 79 TABLE 11 US: CLASSIFICATION OF QUALITY CONTROL MATERIAL 81 TABLE 12 US: TIME, COST, AND COMPLEXITY OF REGISTRATION 82 TABLE 13 CANADA: CLASSIFICATION OF IVD PRODUCTS 82 TABLE 14 CANADA: TIME, COST, AND COMPLEXITY OF REGISTRATION 83 TABLE 15 CLASSIFICATION OF IVD DEVICES IN EUROPE 84 TABLE 16 TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS IN JAPAN 86 TABLE 17 INDIA: TIME, COST, AND COMPLEXITY OF REGISTRATION 87 TABLE 18 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 88 TABLE 19 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 89 TABLE 20 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 89 TABLE 21 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90 TABLE 22 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90 TABLE 23 IVD QUALITY CONTROLS MARKET: KEY CONFERENCES AND EVENTS, 2025–2026 92 TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT & SERVICE (%) 94 TABLE 25 KEY BUYING CRITERIA, BY PRODUCT & SERVICE 95 TABLE 26 RECIPROCAL TARIFF RATES ADJUSTED BY US 100 TABLE 27 IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 104 TABLE 28 KEY IVD QUALITY CONTROL PRODUCTS AVAILABLE IN MARKET 105 TABLE 29 IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 106 TABLE 30 IVD QUALITY CONTROL PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION) 106 TABLE 31 NORTH AMERICA: IVD QUALITY CONTROL PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 106 TABLE 32 EUROPE: IVD QUALITY CONTROL PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 107 TABLE 33 ASIA PACIFIC: IVD QUALITY CONTROL PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 107 TABLE 34 LATIN AMERICA: IVD QUALITY CONTROL PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 108 TABLE 35 MIDDLE EAST & AFRICA: IVD QUALITY CONTROL PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 108 TABLE 36 SERUM/PLASMA-BASED QUALITY CONTROLS OFFERED BY KEY MARKET PLAYERS 109 TABLE 37 SERUM/PLASMA-BASED QUALITY CONTROLS MARKET, BY REGION, 2023–2030 (USD MILLION) 109 TABLE 38 NORTH AMERICA: SERUM/PLASMA-BASED QUALITY CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 110 TABLE 39 EUROPE: SERUM/PLASMA-BASED QUALITY CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 110 TABLE 40 ASIA PACIFIC: SERUM/PLASMA-BASED QUALITY CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 111 TABLE 41 LATIN AMERICA: SERUM/PLASMA-BASED QUALITY CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 111 TABLE 42 MIDDLE EAST & AFRICA: SERUM/PLASMA-BASED QUALITY CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 111 TABLE 43 WHOLE BLOOD-BASED QUALITY CONTROLS OFFERED BY KEY MARKET PLAYERS 112 TABLE 44 WHOLE BLOOD-BASED QUALITY CONTROLS MARKET, BY REGION, 2023–2030 (USD MILLION) 113 TABLE 45 NORTH AMERICA: WHOLE BLOOD-BASED QUALITY CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 113 TABLE 46 EUROPE: WHOLE BLOOD-BASED QUALITY CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 114 TABLE 47 ASIA PACIFIC: WHOLE BLOOD-BASED QUALITY CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 114 TABLE 48 LATIN AMERICA: WHOLE BLOOD-BASED QUALITY CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 115 TABLE 49 MIDDLE EAST & AFRICA: WHOLE BLOOD-BASED QUALITY CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 115 TABLE 50 URINE-BASED QUALITY CONTROLS OFFERED BY KEY MARKET PLAYERS 116 TABLE 51 URINE-BASED QUALITY CONTROLS MARKET, BY REGION, 2023–2030 (USD MILLION) 117 TABLE 52 NORTH AMERICA: URINE-BASED QUALITY CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 117 TABLE 53 EUROPE: URINE-BASED QUALITY CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 118 TABLE 54 ASIA PACIFIC: URINE-BASED QUALITY CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 118 TABLE 55 LATIN AMERICA: URINE-BASED QUALITY CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 119 TABLE 56 MIDDLE EAST & AFRICA: URINE-BASED QUALITY CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 119 TABLE 57 OTHER QUALITY CONTROLS OFFERED BY KEY MARKET PLAYERS 120 TABLE 58 OTHER QUALITY CONTROLS MARKET, BY REGION, 2023–2030 (USD MILLION) 121 TABLE 59 NORTH AMERICA: OTHER QUALITY CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 121 TABLE 60 EUROPE: OTHER QUALITY CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 121 TABLE 61 ASIA PACIFIC: OTHER QUALITY CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 122 TABLE 62 LATIN AMERICA: OTHER QUALITY CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 122 TABLE 63 MIDDLE EAST & AFRICA: OTHER QUALITY CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 122 TABLE 64 DATA MANAGEMENT SOLUTIONS OFFERED BY KEY MARKET PLAYERS 123 TABLE 65 DATA MANAGEMENT SOLUTIONS MARKET, BY REGION, 2023–2030 (USD MILLION) 124 TABLE 66 NORTH AMERICA: DATA MANAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 124 TABLE 67 EUROPE: DATA MANAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 124 TABLE 68 ASIA PACIFIC: DATA MANAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 125 TABLE 69 LATIN AMERICA: DATA MANAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 125 TABLE 70 MIDDLE EAST & AFRICA: DATA MANAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 125 TABLE 71 QUALITY ASSURANCE SERVICES OFFERED BY KEY MARKET PLAYERS 126 TABLE 72 QUALITY ASSURANCE SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 127 TABLE 73 NORTH AMERICA: QUALITY ASSURANCE SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 127 TABLE 74 EUROPE: QUALITY ASSURANCE SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 127 TABLE 75 ASIA PACIFIC: QUALITY ASSURANCE SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 128 TABLE 76 LATIN AMERICA: QUALITY ASSURANCE SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 128 TABLE 77 MIDDLE EAST & AFRICA: QUALITY ASSURANCE SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 128 TABLE 78 IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 130 TABLE 79 QUALITY CONTROLS FOR IMMUNOASSAYS AVAILABLE IN MARKET 131 TABLE 80 IVD QUALITY CONTROLS MARKET FOR IMMUNOASSAYS, BY REGION, 2023–2030 (USD MILLION) 132 TABLE 81 NORTH AMERICA: IVD QUALITY CONTROLS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2023–2030 (USD MILLION) 132 TABLE 82 EUROPE: IVD QUALITY CONTROLS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2023–2030 (USD MILLION) 133 TABLE 83 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2023–2030 (USD MILLION) 133 TABLE 84 LATIN AMERICA: IVD QUALITY CONTROLS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2023–2030 (USD MILLION) 134 TABLE 85 MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2023–2030 (USD MILLION) 134 TABLE 86 QUALITY CONTROLS FOR CLINICAL CHEMISTRY AVAILABLE IN MARKET 135 TABLE 87 IVD QUALITY CONTROLS MARKET FOR CLINICAL CHEMISTRY, BY REGION, 2023–2030 (USD MILLION) 136 TABLE 88 NORTH AMERICA: IVD QUALITY CONTROLS MARKET FOR CLINICAL CHEMISTRY, BY COUNTRY, 2023–2030 (USD MILLION) 136 TABLE 89 EUROPE: IVD QUALITY CONTROLS MARKET FOR CLINICAL CHEMISTRY, BY COUNTRY, 2023–2030 (USD MILLION) 137 TABLE 90 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET FOR CLINICAL CHEMISTRY, BY COUNTRY, 2023–2030 (USD MILLION) 137 TABLE 91 LATIN AMERICA: IVD QUALITY CONTROLS MARKET FOR CLINICAL CHEMISTRY, BY COUNTRY, 2023–2030 (USD MILLION) 138 TABLE 92 MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET FOR CLINICAL CHEMISTRY, BY COUNTRY, 2023–2030 (USD MILLION) 138 TABLE 93 QUALITY CONTROLS FOR MOLECULAR DIAGNOSTICS AVAILABLE IN MARKET 139 TABLE 94 IVD QUALITY CONTROLS MARKET FOR MOLECULAR DIAGNOSTICS, BY REGION, 2023–2030 (USD MILLION) 140 TABLE 95 NORTH AMERICA: IVD QUALITY CONTROLS MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION) 140 TABLE 96 EUROPE: IVD QUALITY CONTROLS MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION) 141 TABLE 97 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION) 141 TABLE 98 LATIN AMERICA: IVD QUALITY CONTROLS MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION) 142 TABLE 99 MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION) 142 TABLE 100 QUALITY CONTROLS FOR MICROBIOLOGY AVAILABLE IN MARKET 143 TABLE 101 IVD QUALITY CONTROLS MARKET FOR MICROBIOLOGY, BY REGION, 2023–2030 (USD MILLION) 143 TABLE 102 NORTH AMERICA: IVD QUALITY CONTROLS MARKET FOR MICROBIOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 144 TABLE 103 EUROPE: IVD QUALITY CONTROLS MARKET FOR MICROBIOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 144 TABLE 104 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET FOR MICROBIOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 145 TABLE 105 LATIN AMERICA: IVD QUALITY CONTROLS MARKET FOR MICROBIOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 145 TABLE 106 MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET FOR MICROBIOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 145 TABLE 107 QUALITY CONTROLS FOR HEMATOLOGY AVAILABLE IN MARKET 146 TABLE 108 IVD QUALITY CONTROLS MARKET FOR HEMATOLOGY, BY REGION, 2023–2030 (USD MILLION) 147 TABLE 109 NORTH AMERICA: IVD QUALITY CONTROLS MARKET FOR HEMATOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 148 TABLE 110 EUROPE: IVD QUALITY CONTROLS MARKET FOR HEMATOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 148 TABLE 111 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET FOR HEMATOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 149 TABLE 112 LATIN AMERICA: IVD QUALITY CONTROLS MARKET FOR HEMATOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 149 TABLE 113 MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET FOR HEMATOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 149 TABLE 114 QUALITY CONTROLS FOR COAGULATION & HEMOSTASIS AVAILABLE IN MARKET 150 TABLE 115 IVD QUALITY CONTROLS MARKET FOR COAGULATION & HEMOSTASIS, BY REGION, 2023–2030 (USD MILLION) 151 TABLE 116 NORTH AMERICA: IVD QUALITY CONTROLS MARKET FOR COAGULATION & HEMOSTASIS, BY COUNTRY, 2023–2030 (USD MILLION) 151 TABLE 117 EUROPE: IVD QUALITY CONTROLS MARKET FOR COAGULATION & HEMOSTASIS, BY COUNTRY, 2023–2030 (USD MILLION) 152 TABLE 118 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET FOR COAGULATION & HEMOSTASIS, BY COUNTRY, 2023–2030 (USD MILLION) 152 TABLE 119 LATIN AMERICA: IVD QUALITY CONTROLS MARKET FOR COAGULATION & HEMOSTASIS, BY COUNTRY, 2023–2030 (USD MILLION) 153 TABLE 120 MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET FOR COAGULATION & HEMOSTASIS, BY COUNTRY, 2023–2030 (USD MILLION) 153 TABLE 121 QUALITY CONTROLS FOR OTHER TECHNOLOGIES AVAILABLE IN MARKET 154 TABLE 122 IVD QUALITY CONTROLS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2023–2030 (USD MILLION) 154 TABLE 123 NORTH AMERICA: IVD QUALITY CONTROLS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION) 155 TABLE 124 EUROPE: IVD QUALITY CONTROLS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION) 155 TABLE 125 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION) 156 TABLE 126 LATIN AMERICA: IVD QUALITY CONTROLS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION) 156 TABLE 127 MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION) 156 TABLE 128 IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023–2030 (USD MILLION) 158 TABLE 129 KEY THIRD-PARTY CONTROLS AVAILABLE IN MARKET 159 TABLE 130 THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023–2030 (USD MILLION) 159 TABLE 131 THIRD-PARTY CONTROLS MARKET, BY REGION, 2023–2030 (USD MILLION) 160 TABLE 132 NORTH AMERICA: THIRD-PARTY CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 160 TABLE 133 EUROPE: THIRD-PARTY CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 160 TABLE 134 ASIA PACIFIC: THIRD-PARTY CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 161 TABLE 135 LATIN AMERICA: THIRD-PARTY CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 161 TABLE 136 MIDDLE EAST & AFRICA: THIRD-PARTY CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 161 TABLE 137 INDEPENDENT THIRD-PARTY CONTROLS AVAILABLE IN MARKET 162 TABLE 138 INDEPENDENT THIRD-PARTY CONTROLS MARKET, BY REGION, 2023–2030 (USD MILLION) 163 TABLE 139 NORTH AMERICA: INDEPENDENT THIRD-PARTY CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 163 TABLE 140 EUROPE: INDEPENDENT THIRD-PARTY CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 164 TABLE 141 ASIA PACIFIC: INDEPENDENT THIRD-PARTY CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 164 TABLE 142 LATIN AMERICA: INDEPENDENT THIRD-PARTY CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 165 TABLE 143 MIDDLE EAST & AFRICA: INDEPENDENT THIRD-PARTY CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 165 TABLE 144 INSTRUMENT-SPECIFIC THIRD-PARTY CONTROLS AVAILABLE IN MARKET 166 TABLE 145 INSTRUMENT-SPECIFIC THIRD-PARTY CONTROLS MARKET, BY REGION, 2023–2030 (USD MILLION) 166 TABLE 146 NORTH AMERICA: INSTRUMENT-SPECIFIC THIRD-PARTY CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 166 TABLE 147 EUROPE: INSTRUMENT-SPECIFIC THIRD-PARTY CONTROLS MARKET, 2023–2030 (USD MILLION) 167 TABLE 148 ASIA PACIFIC: INSTRUMENT-SPECIFIC THIRD-PARTY CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 167 TABLE 149 LATIN AMERICA: INSTRUMENT-SPECIFIC THIRD-PARTY CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 168 TABLE 150 MIDDLE EAST & AFRICA: INSTRUMENT-SPECIFIC THIRD-PARTY CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 168 TABLE 151 OEM CONTROLS AVAILABLE IN MARKET 169 TABLE 152 OEM CONTROLS MARKET, BY REGION, 2023–2030 (USD MILLION) 170 TABLE 153 NORTH AMERICA: OEM CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 170 TABLE 154 EUROPE: OEM CONTROLS MARKET, 2023–2030 (USD MILLION) 170 TABLE 155 ASIA PACIFIC: OEM CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 171 TABLE 156 LATIN AMERICA: OEM CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 171 TABLE 157 MIDDLE EAST & AFRICA: OEM CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 171 TABLE 158 IVD QUALITY CONTROLS MARKET, BY END USER, 2023–2030 (USD MILLION) 173 TABLE 159 IVD QUALITY CONTROLS MARKET FOR HOSPITALS, BY REGION, 2023–2030 (USD MILLION) 174 TABLE 160 NORTH AMERICA: IVD QUALITY CONTROLS MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION) 174 TABLE 161 EUROPE: IVD QUALITY CONTROLS MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION) 175 TABLE 162 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION) 175 TABLE 163 LATIN AMERICA: IVD QUALITY CONTROLS MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION) 176 TABLE 164 MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION) 176 TABLE 165 IVD QUALITY CONTROLS MARKET FOR CLINICAL LABORATORIES, BY REGION, 2023–2030 (USD MILLION) 177 TABLE 166 NORTH AMERICA: IVD QUALITY CONTROLS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 177 TABLE 167 EUROPE: IVD QUALITY CONTROLS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 178 TABLE 168 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 178 TABLE 169 LATIN AMERICA: IVD QUALITY CONTROLS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 179 TABLE 170 MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 179 TABLE 171 IVD QUALITY CONTROLS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION) 180 TABLE 172 NORTH AMERICA: IVD QUALITY CONTROLS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 180 TABLE 173 EUROPE: IVD QUALITY CONTROLS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 181 TABLE 174 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 181 TABLE 175 LATIN AMERICA: IVD QUALITY CONTROLS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 182 TABLE 176 MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 182 TABLE 177 IVD QUALITY CONTROLS MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD MILLION) 183 TABLE 178 NORTH AMERICA: IVD QUALITY CONTROLS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 183 TABLE 179 EUROPE: IVD QUALITY CONTROLS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 184 TABLE 180 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 184 TABLE 181 LATIN AMERICA: IVD QUALITY CONTROLS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 185 TABLE 182 MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 185 TABLE 183 IVD QUALITY CONTROLS MARKET, BY REGION, 2023–2030 (USD MILLION) 187 TABLE 184 NORTH AMERICA: MACROECONOMIC INDICATORS 189 TABLE 185 NORTH AMERICA: IVD QUALITY CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 189 TABLE 186 NORTH AMERICA: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 189 TABLE 187 NORTH AMERICA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 190 TABLE 188 NORTH AMERICA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 190 TABLE 189 NORTH AMERICA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023–2030 (USD MILLION) 191 TABLE 190 NORTH AMERICA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023–2030 (USD MILLION) 191 TABLE 191 NORTH AMERICA: IVD QUALITY CONTROLS MARKET, BY END USER, 2023–2030 (USD MILLION) 191 TABLE 192 US: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 193 TABLE 193 US: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 193 TABLE 194 US: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 194 TABLE 195 US: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023–2030 (USD MILLION) 194 TABLE 196 US: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023–2030 (USD MILLION) 194 TABLE 197 US: IVD QUALITY CONTROLS MARKET, BY END USER, 2023–2030 (USD MILLION) 195 TABLE 198 US: NUMBER OF IN VITRO DIAGNOSTICS TESTS CONDUCTED, 2022–2030 (BILLION) 195 TABLE 199 CANADA: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 196 TABLE 200 CANADA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 196 TABLE 201 CANADA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 197 TABLE 202 CANADA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023–2030 (USD MILLION) 197 TABLE 203 CANADA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023–2030 (USD MILLION) 197 TABLE 204 CANADA: IVD QUALITY CONTROLS MARKET, BY END USER, 2023–2030 (USD MILLION) 198 TABLE 205 EUROPE: MACROECONOMIC INDICATORS 199 TABLE 206 EUROPE: IVD QUALITY CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 199 TABLE 207 EUROPE: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 199 TABLE 208 EUROPE: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 200 TABLE 209 EUROPE: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 200 TABLE 210 EUROPE: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023–2030 (USD MILLION) 201 TABLE 211 EUROPE: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023–2030 (USD MILLION) 201 TABLE 212 EUROPE: IVD QUALITY CONTROLS MARKET, BY END USER, 2023–2030 (USD MILLION) 201 TABLE 213 GERMANY: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 203 TABLE 214 GERMANY: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 203 TABLE 215 GERMANY: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 204 TABLE 216 GERMANY: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023–2030 (USD MILLION) 204 TABLE 217 GERMANY: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023–2030 (USD MILLION) 204 TABLE 218 GERMANY: IVD QUALITY CONTROLS MARKET, BY END USER, 2023–2030 (USD MILLION) 205 TABLE 219 UK: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 206 TABLE 220 UK: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 206 TABLE 221 UK: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 206 TABLE 222 UK: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023–2030 (USD MILLION) 207 TABLE 223 UK: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023–2030 (USD MILLION) 207 TABLE 224 UK: IVD QUALITY CONTROLS MARKET, BY END USER, 2023–2030 (USD MILLION) 207 TABLE 225 FRANCE: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 208 TABLE 226 FRANCE: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 209 TABLE 227 FRANCE: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 209 TABLE 228 FRANCE: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023–2030 (USD MILLION) 210 TABLE 229 FRANCE: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023–2030 (USD MILLION) 210 TABLE 230 FRANCE: IVD QUALITY CONTROLS MARKET, BY END USER, 2023–2030 (USD MILLION) 210 TABLE 231 ITALY: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 211 TABLE 232 ITALY: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 212 TABLE 233 ITALY: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 212 TABLE 234 ITALY: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023–2030 (USD MILLION) 212 TABLE 235 ITALY: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023–2030 (USD MILLION) 213 TABLE 236 ITALY: IVD QUALITY CONTROLS MARKET, BY END USER, 2023–2030 (USD MILLION) 213 TABLE 237 SPAIN: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 214 TABLE 238 SPAIN: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 214 TABLE 239 SPAIN: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 215 TABLE 240 SPAIN: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023–2030 (USD MILLION) 215 TABLE 241 SPAIN: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023–2030 (USD MILLION) 215 TABLE 242 SPAIN: IVD QUALITY CONTROLS MARKET, BY END USER, 2023–2030 (USD MILLION) 216 TABLE 243 RUSSIA: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 217 TABLE 244 RUSSIA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 217 TABLE 245 RUSSIA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 218 TABLE 246 RUSSIA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023–2030 (USD MILLION) 218 TABLE 247 RUSSIA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023–2030 (USD MILLION) 218 TABLE 248 RUSSIA: IVD QUALITY CONTROLS MARKET, BY END USER, 2023–2030 (USD MILLION) 219 TABLE 249 REST OF EUROPE: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 220 TABLE 250 REST OF EUROPE: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 220 TABLE 251 REST OF EUROPE: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 221 TABLE 252 REST OF EUROPE: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023–2030 (USD MILLION) 221 TABLE 253 REST OF EUROPE: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023–2030 (USD MILLION) 221 TABLE 254 REST OF EUROPE: IVD QUALITY CONTROLS MARKET, BY END USER, 2023–2030 (USD MILLION) 222 TABLE 255 ASIA PACIFIC: MACROECONOMIC INDICATORS 223 TABLE 256 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 224 TABLE 257 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 224 TABLE 258 ASIA PACIFIC: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 225 TABLE 259 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 225 TABLE 260 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023–2030 (USD MILLION) 226 TABLE 261 ASIA PACIFIC: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023–2030 (USD MILLION) 226 TABLE 262 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY END USER, 2023–2030 (USD MILLION) 226 TABLE 263 CHINA: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 228 TABLE 264 CHINA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 228 TABLE 265 CHINA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 229 TABLE 266 CHINA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023–2030 (USD MILLION) 229 TABLE 267 CHINA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023–2030 (USD MILLION) 229 TABLE 268 CHINA: IVD QUALITY CONTROLS MARKET, BY END USER, 2023–2030 (USD MILLION) 230 TABLE 269 JAPAN: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 231 TABLE 270 JAPAN: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 231 TABLE 271 JAPAN: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 232 TABLE 272 JAPAN: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023–2030 (USD MILLION) 232 TABLE 273 JAPAN: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023–2030 (USD MILLION) 232 TABLE 274 JAPAN: IVD QUALITY CONTROLS MARKET, BY END USER, 2023–2030 (USD MILLION) 233 TABLE 275 INDIA: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 234 TABLE 276 INDIA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 234 TABLE 277 INDIA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 235 TABLE 278 INDIA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023–2030 (USD MILLION) 235 TABLE 279 INDIA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023–2030 (USD MILLION) 235 TABLE 280 INDIA: IVD QUALITY CONTROLS MARKET, BY END USER, 2023–2030 (USD MILLION) 236 TABLE 281 AUSTRALIA: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 237 TABLE 282 AUSTRALIA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 237 TABLE 283 AUSTRALIA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 238 TABLE 284 AUSTRALIA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023–2030 (USD MILLION) 238 TABLE 285 AUSTRALIA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023–2030 (USD MILLION) 238 TABLE 286 AUSTRALIA: IVD QUALITY CONTROLS MARKET, BY END USER, 2023–2030 (USD MILLION) 239 TABLE 287 SOUTH KOREA: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 240 TABLE 288 SOUTH KOREA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 240 TABLE 289 SOUTH KOREA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 241 TABLE 290 SOUTH KOREA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023–2030 (USD MILLION) 241 TABLE 291 SOUTH KOREA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023–2030 (USD MILLION) 241 TABLE 292 SOUTH KOREA: IVD QUALITY CONTROLS MARKET, BY END USER, 2023–2030 (USD MILLION) 242 TABLE 293 REST OF ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 243 TABLE 294 REST OF ASIA PACIFIC: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 243 TABLE 295 REST OF ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 244 TABLE 296 REST OF ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023–2030 (USD MILLION) 244 TABLE 297 REST OF ASIA PACIFIC: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023–2030 (USD MILLION) 244 TABLE 298 REST OF ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY END USER, 2023–2030 (USD MILLION) 245 TABLE 299 LATIN AMERICA: MACROECONOMIC INDICATORS 246 TABLE 300 LATIN AMERICA: IVD QUALITY CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 246 TABLE 301 LATIN AMERICA: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 246 TABLE 302 LATIN AMERICA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 247 TABLE 303 LATIN AMERICA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 247 TABLE 304 LATIN AMERICA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023–2030 (USD MILLION) 248 TABLE 305 LATIN AMERICA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023–2030 (USD MILLION) 248 TABLE 306 LATIN AMERICA: IVD QUALITY CONTROLS MARKET, BY END USER, 2023–2030 (USD MILLION) 248 TABLE 307 BRAZIL: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 250 TABLE 308 BRAZIL: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 250 TABLE 309 BRAZIL: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 251 TABLE 310 BRAZIL: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023–2030 (USD MILLION) 251 TABLE 311 BRAZIL: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023–2030 (USD MILLION) 251 TABLE 312 BRAZIL: IVD QUALITY CONTROLS MARKET, BY END USER, 2023–2030 (USD MILLION) 252 TABLE 313 MEXICO: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 253 TABLE 314 MEXICO: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 253 TABLE 315 MEXICO: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 254 TABLE 316 MEXICO: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023–2030 (USD MILLION) 254 TABLE 317 MEXICO: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023–2030 (USD MILLION) 254 TABLE 318 MEXICO: IVD QUALITY CONTROLS MARKET, BY END USER, 2023–2030 (USD MILLION) 255 TABLE 319 REST OF LATIN AMERICA: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 256 TABLE 320 REST OF LATIN AMERICA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 256 TABLE 321 REST OF LATIN AMERICA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 257 TABLE 322 REST OF LATIN AMERICA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023–2030 (USD MILLION) 257 TABLE 323 REST OF LATIN AMERICA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023–2030 (USD MILLION) 257 TABLE 324 REST OF LATIN AMERICA: IVD QUALITY CONTROLS MARKET, BY END USER, 2023–2030 (USD MILLION) 258 TABLE 325 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 259 TABLE 326 MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 259 TABLE 327 MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 259 TABLE 328 MIDDLE EAST & AFRICA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 260 TABLE 329 MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 260 TABLE 330 MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023–2030 (USD MILLION) 261 TABLE 331 MIDDLE EAST & AFRICA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023–2030 (USD MILLION) 261 TABLE 332 MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET, BY END USER, 2023–2030 (USD MILLION) 261 TABLE 333 SAUDI ARABIA: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 263 TABLE 334 SAUDI ARABIA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 263 TABLE 335 SAUDI ARABIA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 264 TABLE 336 SAUDI ARABIA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023–2030 (USD MILLION) 264 TABLE 337 SAUDI ARABIA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023–2030 (USD MILLION) 264 TABLE 338 SAUDI ARABIA: IVD QUALITY CONTROLS MARKET, BY END USER, 2023–2030 (USD MILLION) 265 TABLE 339 UAE: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 266 TABLE 340 UAE: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 266 TABLE 341 UAE: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 267 TABLE 342 UAE: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023–2030 (USD MILLION) 267 TABLE 343 UAE: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023–2030 (USD MILLION) 267 TABLE 344 UAE: IVD QUALITY CONTROLS MARKET, BY END USER, 2023–2030 (USD MILLION) 268 TABLE 345 REST OF MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 269 TABLE 346 REST OF MIDDLE EAST & AFRICA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 269 TABLE 347 REST OF MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 270 TABLE 348 REST OF MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023–2030 (USD MILLION) 270 TABLE 349 REST OF MIDDLE EAST & AFRICA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023–2030 (USD MILLION) 270 TABLE 350 REST OF MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET, BY END USER, 2023–2030 (USD MILLION) 271 TABLE 351 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES IN IVD QUALITY CONTROLS MARKET, JANUARY 2021−AUGUST 2025 273 TABLE 352 IVD QUALITY CONTROLS MARKET: DEGREE OF COMPETITION 276 TABLE 353 IVD QUALITY CONTROLS MARKET: REGION FOOTPRINT 281 TABLE 354 IVD QUALITY CONTROLS MARKET: PRODUCT & SERVICE FOOTPRINT 282 TABLE 355 IVD QUALITY CONTROLS MARKET: TECHNOLOGY FOOTPRINT 283 TABLE 356 IVD QUALITY CONTROLS MARKET: MANNUFACTURER TYPE FOOTPRINT 284 TABLE 357 IVD QUALITY CONTROLS MARKET: DETAILED LIST OF KEY STARTUPS/SMES 287 TABLE 358 IVD QUALITY CONTROLS MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY PRODUCT & SERVICE AND MANUFACTURER TYPE 287 TABLE 359 IVD QUALITY CONTROLS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES, BY REGION 288 TABLE 360 IVD QUALITY CONTROLS MARKET: PRODUCT & SERVICE LAUNCHES AND APPROVALS, JANUARY 2021–AUGUST 2025 290 TABLE 361 IVD QUALITY CONTROLS MARKET: DEALS, JANUARY 2021–AUGUST 2025 291 TABLE 362 IVD QUALITY CONTROLS MARKET: EXPANSIONS, JANUARY 2021–AUGUST 2025 292 TABLE 363 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 293 TABLE 364 BIO-RAD LABORATORIES, INC.: PRODUCTS & SERVICES OFFERED 294 TABLE 365 BIO-RAD LABORATORIES, INC.: PRODUCT & SERVICE LAUNCHES, JANUARY 2021–AUGUST 2025 299 TABLE 366 BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2021–AUGUST 2025 299 TABLE 367 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 301 TABLE 368 THERMO FISHER SCIENTIFIC INC.: PRODUCTS & SERVICES OFFERED 302 TABLE 369 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021–AUGUST 2025 304 TABLE 370 ABBOTT: COMPANY OVERVIEW 306 TABLE 371 ABBOTT: PRODUCTS & SERVICES OFFERED 307 TABLE 372 LGC LIMITED: COMPANY OVERVIEW 310 TABLE 373 LGC LIMITED: PRODUCTS & SERVICES OFFERED 311 TABLE 374 LGC LIMITED: DEALS, JANUARY 2021–AUGUST 2025 314 TABLE 375 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW 316 TABLE 376 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS & SERVICES OFFERED 317 TABLE 377 F. HOFFMANN-LA ROCHE LTD.: DEALS, JANUARY 2021–AUGUST 2025 318 TABLE 378 RANDOX LABORATORIES LTD.: COMPANY OVERVIEW 320 TABLE 379 RANDOX LABORATORIES LTD.: PRODUCTS & SERVICES OFFERED 320 TABLE 380 RANDOX LABORATORIES LTD.: PRODUCT & SERVICE LAUNCHES, JANUARY 2021–AUGUST 2025 324 TABLE 381 RANDOX LABORATORIES LTD.: DEALS, JANUARY 2021–AUGUST 2025 324 TABLE 382 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW 325 TABLE 383 SIEMENS HEALTHINEERS AG: PRODUCTS & SERVICES OFFERED 326 TABLE 384 QUIDELORTHO CORPORATION: COMPANY OVERVIEW 327 TABLE 385 QUIDELORTHO CORPORATION: PRODUCTS & SERVICES OFFERED 328 TABLE 386 QUIDELORTHO CORPORATION: DEALS, JANUARY 2021–AUGUST 2025 330 TABLE 387 QUIDELORTHO CORPORATION: EXPANSIONS, JANUARY 2021–AUGUST 2025 330 TABLE 388 DANAHER CORPORATION: COMPANY OVERVIEW 331 TABLE 389 DANAHER CORPORATION: PRODUCTS & SERVICES OFFERED 332 TABLE 390 SYSMEX CORPORATION: COMPANY OVERVIEW 334 TABLE 391 SYSMEX CORPORATION: PRODUCTS & SERVICES OFFERED 335 TABLE 392 SYSMEX CORPORATION: PRODUCT & SERVICE LAUNCHES, JANUARY 2021–AUGUST 2025 336 TABLE 393 SYSMEX CORPORATION: DEALS, JANUARY 2021–AUGUST 2025 336 TABLE 394 SYSMEX CORPORATION: EXPANSIONS, JANUARY 2021–AUGUST 2025 337 TABLE 395 BIO-TECHNE CORPORATION: BUSINESS OVERVIEW 339 TABLE 396 BIO-TECHNE CORPORATION: PRODUCTS & SERVICES OFFERED 340 TABLE 397 BIO-TECHNE CORPORATION: PRODUCT & SERVICE LAUNCHES, JANUARY 2021–AUGUST 2025 344 TABLE 398 BIO-TECHNE CORPORATION: DEALS, JANUARY 2021–AUGUST 2025 344 TABLE 399 BIO-TECHNE CORPORATION: EXPANSIONS, JANUARY 2021–AUGUST 2025 345 TABLE 400 MICROBIX BIOSYSTEMS INC.: COMPANY OVERVIEW 346 TABLE 401 MICROBIX BIOSYSTEMS INC.: PRODUCTS & SERVICES OFFERED 347 TABLE 402 MICROBIX BIOSYSTEMS INC.: PRODUCT & SERVICE LAUNCHES, JANUARY 2021–AUGUST 2025 348 TABLE 403 MICROBIX BIOSYSTEMS INC.: DEALS, JANUARY 2021–AUGUST 2025 349 TABLE 404 GRIFOLS, S.A.: COMPANY OVERVIEW 351 TABLE 405 GRIFOLS, S.A.: PRODUCTS & SERVICES OFFERED 352 TABLE 406 MICROBIOLOGICS, INC.: COMPANY OVERVIEW 353 TABLE 407 MICROBIOLOGICS, INC.: PRODUCTS & SERVICES OFFERED 353 TABLE 408 MICROBIOLOGICS, INC.: DEALS, JANUARY 2021–AUGUST 2025 355 TABLE 409 ZEPTOMETRIX: COMPANY OVERVIEW 356 TABLE 410 ZEPTOMETRIX: PRODUCTS & SERVICES OFFERED 356 TABLE 411 ZEPTOMETRIX: PRODUCT & SERVICE LAUNCHES & APPROVALS, JANUARY 2021–AUGUST 2025 357 TABLE 412 FORTRESS DIAGNOSTICS: COMPANY OVERVIEW 359 TABLE 413 FORTRESS DIAGNOSTICS: PRODUCTS & SERVICES OFFERED 359 TABLE 414 HELENA LABORATORIES CORPORATION: COMPANY OVERVIEW 362 TABLE 415 STRECK, INC.: COMPANY OVERVIEW 363 TABLE 416 MAINE MOLECULAR QUALITY CONTROLS, INC.: COMPANY OVERVIEW 364 TABLE 417 SUN DIAGNOSTICS, LLC: COMPANY OVERVIEW 366 TABLE 418 SERO AS: COMPANY OVERVIEW 366 TABLE 419 CONEBIOPRODUCTS: COMPANY OVERVIEW 367 TABLE 420 ALPHA-TEC: COMPANY OVERVIEW 368 TABLE 421 EUROTROL B.V.: COMPANY OVERVIEW 369 TABLE 422 BIOREX DIAGNOSTICS: COMPANY OVERVIEW 370 FIGURE 1 IVD QUALITY CONTROLS MARKET SEGMENTATION & REGIONAL SCOPE 35 FIGURE 2 IVD QUALITY CONTROLS MARKET: RESEARCH DESIGN METHODOLOGY 39 FIGURE 3 PRIMARY SOURCES 42 FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 44 FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 45 FIGURE 6 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 46 FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 47 FIGURE 8 IVD QUALITY CONTROLS MARKET: TOP-DOWN APPROACH 48 FIGURE 9 DATA TRIANGULATION METHODOLOGY 49 FIGURE 10 IVD QUALITY CONTROLS MARKET: RESEARCH ASSUMPTIONS 50 FIGURE 11 IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2025 VS. 2030 (USD MILLION) 52 FIGURE 12 IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION) 53 FIGURE 13 IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2025 VS. 2030 (USD MILLION) 54 FIGURE 14 IVD QUALITY CONTROLS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 54 FIGURE 15 IVD QUALITY CONTROLS MARKET, BY REGION, 2025 VS. 2030 (USD MILLION) 55 FIGURE 16 GROWING ADOPTION OF THIRD-PARTY CONTROLS AND INCREASING DEMAND FOR EXTERNAL QUALITY ASSESSMENT TO DRIVE MARKET 56 FIGURE 17 QUALITY CONTROL PRODUCTS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 57 FIGURE 18 IMMUNOASSAYS SEGMENT TO SHOWCASE LARGEST MARKET SHARE DURING FORECAST PERIOD 57 FIGURE 19 THIRD-PARTY CONTROLS SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD 58 FIGURE 20 HOSPITALS SEGMENT TO CONTINUE TO DOMINATE MARKET IN 2030 58 FIGURE 21 NORTH AMERICAN MARKET TO ACCOUNT FOR LARGEST SHARE DURING FORECAST PERIOD 59 FIGURE 22 IVD QUALITY CONTROLS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 60 FIGURE 23 NUMBER OF CLIA-ACCREDITED LABORATORIES, BY ACCREDITATION ORGANIZATION (2024) 61 FIGURE 24 PATENT ANALYSIS FOR QUALITY CONTROLS FOR DIAGNOSTICS, JANUARY 2015–DECEMBER 2024 71 FIGURE 25 IVD QUALITY CONTROLS MARKET: VALUE CHAIN ANALYSIS 73 FIGURE 26 IVD QUALITY CONTROLS MARKET: SUPPLY CHAIN ANALYSIS 75 FIGURE 27 IVD QUALITY CONTROLS MARKET: ECOSYSTEM ANALYSIS 77 FIGURE 28 IVD QUALITY CONTROLS MARKET: PORTER’S FIVE FORCES ANALYSIS 79 FIGURE 29 IVD QUALITY CONTROLS MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 93 FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT & SERVICE 94 FIGURE 31 KEY BUYING CRITERIA, BY PRODUCT & SERVICE 94 FIGURE 32 NUMBER OF DEALS & FUNDING ACTIVITIES IN IVD QUALITY CONTROLS MARKET 95 FIGURE 33 MARKET POTENTIAL OF AI IN IVD QUALITY CONTROLS MARKET 97 FIGURE 34 NORTH AMERICA: IVD QUALITY CONTROLS MARKET SNAPSHOT 188 FIGURE 35 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET SNAPSHOT 223 FIGURE 36 REVENUE ANALYSIS OF KEY PLAYERS IN IVD QUALITY CONTROLS MARKET (2022–2024) 275 FIGURE 37 MARKET SHARE ANALYSIS OF KEY PLAYERS IN IVD QUALITY CONTROLS MARKET (2024) 276 FIGURE 38 IVD QUALITY CONTROLS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 279 FIGURE 39 IVD QUALITY CONTROLS MARKET: COMPANY FOOTPRINT 280 FIGURE 40 IVD QUALITY CONTROLS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 286 FIGURE 41 EV/EBITDA OF KEY VENDORS 288 FIGURE 42 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 289 FIGURE 43 IVD QUALITY CONTROLS MARKET: BRAND COMPARISON 289 FIGURE 44 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2024) 294 FIGURE 45 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024) 302 FIGURE 46 ABBOTT: COMPANY SNAPSHOT (2024) 307 FIGURE 47 LGC LIMITED: COMPANY SNAPSHOT (2023) 311 FIGURE 48 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2024) 317 FIGURE 49 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2024) 326 FIGURE 50 QUIDELORTHO CORPORATION: COMPANY SNAPSHOT (2024) 328 FIGURE 51 DANAHER CORPORATION: COMPANY SNAPSHOT (2024) 332 FIGURE 52 SYSMEX CORPORATION: COMPANY SNAPSHOT (2024) 335 FIGURE 53 BIO-TECHNE CORPORATION: COMPANY SNAPSHOT (2024) 340 FIGURE 54 MICROBIX BIOSYSTEMS INC.: COMPANY SNAPSHOT (2024) 347 FIGURE 55 GRIFOLS, S.A.: COMPANY SNAPSHOT (2024) 352

同分類最新報告（醫療器材）

查看醫療器材全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們